“Ampyra is giving me the confidence to know that I can get from here to there.” –Rick

Connect to Support — Welcome to the AMPYRACONNECT™ Support Program

The AMPYRACONNECT™ Support Program provides support for people with multiple sclerosis (MS) who take AMPYRA® (dalfampridine) and their care partners. This free program is designed to inform, educate and motivate you as you begin your treatment with AMPYRA.

Register online today and receive AMPYRA information, upcoming events, tips and tools, and exclusive web-based material.

You can look forward to:

  • Tips on taking your AMPYRA prescription safely and effectively
  • Up-to-date information about AMPYRA and walking
  • Upcoming MS events and educational seminars
  • Exclusive web-based material
  • Ongoing tips, tools and more

Provide your AMPYRACONNECT™ access code below

Where do I get this number?

Have more questions?

Remember, we are on the line and online to provide answers when you need them. If you have questions about AMPYRA, call AMPYRA Patient Support Services (APSS) toll-free at 1-888-881-1918 Monday through Friday, from 8 am to 8 pm ET.

The AMPYRACONNECT™ Support Program is for those who've already been prescribed AMPYRA. If you are still trying to determine whether AMPYRA might be for you, you can sign up for Walk Talk, our email program designed to give you additional information about AMPYRA and walking with MS.

AMPYRA® (dalfampridine) is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

IMPORTANT SAFETY INFORMATION

Do not take AMPYRA if you have ever had a seizure, or have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Take AMPYRA exactly as prescribed by your doctor.

You could have a seizure even if you never had a seizure before. Your chance of having a seizure is higher if you take too much AMPYRA or if your kidneys have a mild decrease of function, which is common after age 50.

Your doctor may do a blood test to check how well your kidneys are working, if that is not known before you start taking AMPYRA.

AMPYRA may cause serious allergic reactions. Stop taking AMPYRA and call your doctor right away or get emergency medical help if you have shortness of breath or trouble breathing, swelling of your throat or tongue, or hives.

AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same.

The most common adverse events for AMPYRA in MS patients were urinary tract infection, trouble sleeping, dizziness, headache, nausea, weakness, back pain, and problems with balance.

Before taking AMPYRA tell your doctor if you are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.

Tell your doctor if you are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into your breast milk. You and your doctor should decide if you will take AMPYRA or breast-feed. You should not do both.

Please see the full Prescribing Information and Patient Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

AMPYRA®, ACORDA THERAPEUTICS® and the stylized ACORDA THERAPEUTICS® logo are registered trademarks of Acorda Therapeutics, Inc. | AMPYRA® is marketed by Acorda Therapeutics, Inc. and manufactured under license from Alkermes Pharma Ireland Limited (APIL), Ireland. | AMPYRACONNECT™ is a trademark of Acorda Therapeutics, Inc. | The stylized path logo and the stylized Acorda logo are trademarks of Acorda Therapeutics, Inc. | © 2013 Acorda Therapeutics, Inc. All rights reserved.

AMP2043